BUDAPEST, Hungary and ATLANTA, June 18, 2019 /PRNewswire/ -- Intrexon Corporation (Int...查看全文
越炒股越美2019-03-06 17:38
【Top6医药股盘点:XON上涨21.26%,涨幅最大】
$Intrexon(XON)$ $Bionano Genomics(BNGO)$$Anavex Life Sciences(AVXL)$ 3月5日涨幅最大的医药股分别是:生物技术公司 Intrexon Corporation 上涨21.26%;生命科学仪器公司Bionano上涨19.32% ;Anavex 生命科学公司上涨13.90等。 查看全文https:...查看全文
Just-a-Novice2018-02-23 13:14
The biggest challenge for tiny companies without successful history is visibility-----you struggle to distinguish speculation and solid judgements with reliable casual link; you struggle to judge if a claimed groundbreaking technology/product is really good or not; and you st...查看全文
$Intrexon(XON)$ 8-K - Current report Filed: 2019-02-28 AccNo: 0001193125-19-057969 Size: 10 MBItem 2.02: Results of Operations and Financial ConditionItem 7.01: Regulation FD DisclosureItem 9.01: Financial Statements and Exhibits 网页链接
$Intrexon(XON)$ 美东时间 2019-02-28 盘后 披露财报,预期EPS -0.29 网页链接
$Intrexon(XON)$ 内部交易: 2019-02-12,Director,Frank Steven ,期权,2968普通股, $3.17
$Intrexon(XON)$ 内部交易: 2019-02-07,Chief Science Officer,Reed Thomas D. ,期权,2969普通股, $3.17
$Intrexon(XON)$ SC 13G - Statement of acquisition of beneficial ownership by individuals Filed: 2019-01-07 AccNo: 0001144204-19-000901 Size: 114 KB 网页链接
$Intrexon(XON)$ 8-K - Current report Filed: 2019-01-07 AccNo: 0001193125-19-003911 Size: 10 MBItem 7.01: Regulation FD DisclosureItem 9.01: Financial Statements and Exhibits 网页链接
$Intrexon(XON)$ 内部交易: 2019-01-03,Chief Business Officer,Nimrodi Nir ,卖出,4058普通股, $7.07
$Intrexon(XON)$ 内部交易: 2019-01-04,SVP, Finance,LIFFMAN JOEL D ,卖出,3725普通股, $7.03
$Intrexon(XON)$ 内部交易: 2019-01-03,SVP, Energy & Fine Chem.,Walsh Robert F. III ,卖出,4058普通股, $7.07
$Intrexon(XON)$ 内部交易: 2019-01-03,CFO,Sterling Rick L. ,卖出,3514普通股, $7.07